NEW YORK ( TheStreet) -- Drug company GlaxoSmithKline (GSK - Get Report) announced Monday that it is acquiring 10 million shares of biopharmaceutical firm Theravance (THRX - Get Report) for about $212.9 million.
GlaxoSmithKline currently owns 18.3% of Theravance and the acquisition would increase its ownership to 26.8%.
-- Written by Alexandra Zendrian
>To contact the writer of this article, click here: Alexandra Zendrian
>To submit a news tip, send an email to: firstname.lastname@example.org.>To follow the writer on Twitter, go to Alexandra Zendrian.